ProCE Banner Activity

Emerging Scientific Data and Unique Clinical Scenarios in People With NTM Lung Disease

Podcast Episodes

Listen to Shannon Kasperbauer, MD, discuss emerging scientific data and unique clinical scenarios in people with nontuberculous mycobacterial (NTM) lung disease, specifically focusing on Mycobacteroides abscessus.

Released: October 31, 2023

Share

Faculty

Charles L. Daley

Charles L. Daley, MD

Professor of Medicine
Division of Mycobacterial and Respiratory Infections Department of Medicine
National Jewish Health
Denver, Colorado

Shannon Kasperbauer

Shannon Kasperbauer, MD

Associate Professor of Medicine
Division of Mycobacterial and Respiratory Infections
National Jewish Health
Denver, Colorado

Pamela J. McShane

Pamela J. McShane, MD

Professor of Medicine
Division of Pulmonary and Critical Care Medicine
The University of Texas Health
Science Center at Tyler
Tyler, Texas

Provided by

Provided by Clinical Care Options, LLC, produced in partnership with NTM Info & Research (NTMir).

ProCE Banner

Supporters

Supported by an educational grant from Insmed Incorporated.

Insmed Incorporated

Partners

NTMIR

ProCE Banner

Disclosure

Program Director

Charles L. Daley, MD

Professor of Medicine
Division of Mycobacterial and Respiratory Infections Department of Medicine
National Jewish Health
Denver, Colorado

Charles L. Daley, MD: consultant/advisor/speaker: AN2, AstraZeneca, Cepheid, Hyfe, Insmed, Lilly, Mannkind, Matinas BioPharma, NobHill, Otsuka, Spero Therapeutics, Zambon; researcher: AN2, Bugworks, Insmed, Juvabis, Paratek.

Primary Author

Shannon Kasperbauer, MD

Associate Professor of Medicine
Division of Mycobacterial and Respiratory Infections
National Jewish Health
Denver, Colorado

Shannon Kasperbauer, MD: consultant/advisor/speaker: AN2, Insmed, Paratek; investigator: Renovion. 

Pamela J. McShane, MD

Professor of Medicine
Division of Pulmonary and Critical Care Medicine
The University of Texas Health
Science Center at Tyler
Tyler, Texas

Pamela J. McShane, MD: researcher: AN2 Therapeutics, Armata, Boehringher Ingelheim, Electromed, Insmed, MannKind, Paratek, Renovian, Spero; data monitoring committee: GREAT-2; advisor: Boehringer Ingelheim, Insmed, Spero.